Paco E. Bravo, MD

Director of Nuclear Cardiology and Cardiovascular Molecular Imaging
Hospital of the University of Pennsylvania

Paco E. Bravo, MD; Assistant Professor of Radiology and Medicine; Divisions of Nuclear Medicine, Cardiothoracic Imaging and Cardiovascular Medicine
Director, Nuclear Cardiology and Cardiovascular Molecular Imaging; Hospital of the University of Pennsylvania
Dr. Bravo has a particular interest in the complementary role of radionuclide molecular imaging techniques and tissue characterization with contrast-enhanced cardiac magnetic resonance imaging for sub-clinical detection, phenotyping, diagnosis, and risk stratification of individuals with various forms of cardiomyopathy.

Presentation(s):

• Phenotyping Individuals with Suspected Cardiac Sarcoidosis with CMR and PET: Focus on Outcomes (RF_TH_197)

  Thursday, January 30, 2025
  2:10 PM – 2:20 PM East Coast USA Time

• Quick Fire 2-Non-Ischemic Cardiomyopathies II (Kiosk 3)

  Thursday, January 30, 2025
  4:20 PM – 5:20 PM East Coast USA Time

• Susceptibility, Infarct Characteristics, and Reactive Oxygen Species in Myocardial Infarction Reperfusion Injury (RF_FR_353)

  Friday, January 31, 2025
  11:40 AM – 11:50 AM East Coast USA Time

• T2 mapping has limited performance in predicting FDG-defined myocardial inflammation in patients with suspected cardiac sarcoidosis (RF_FR_414)

  Friday, January 31, 2025
  3:30 PM – 3:40 PM East Coast USA Time